Finding a gene associated with disease is one thing. Understanding how it increases the likelihood of contracting that disease can be quite another, especially a complex condition like heart disease. After five years, Heart Institute researchers now know how one genetic variant works and suspect
The second annual Ottawa Heart Research Conference convened on May 8, bringing together an enthusiastic community of scientists and trainees to share insights on personalized cardiovascular medicine. The theme was chosen in honour of former University of Ottawa Heart Institute President and CEO
The past decade has seen rapid progress in cataloguing the genetic factors driving heart disease risk. The University of Ottawa Heart Institute led the way, discovering the first and, to date, highest-impact common genetic variant linked to coronary artery disease. Many others have been found since
Statins, cholesterol-lowering drugs, have become one of the most widely prescribed classes of drugs ever produced. The medication is used to treat coronary artery disease (atherosclerosis). We discuss the benefits and risks of these drugs.
Lana Gillard was used to going to the University of Ottawa Heart Institute. Her mother was a long-time patient there, suffering from chronic heart failure after many years of treatment and several open-heart surgeries. Gillard accompanied her to appointments and knew her mother was in excellent
A complex condition that is not well understood, cardiac sarcoidosis (CS) can affect the electrical pathways in the heart and cause potentially serious irregular heartbeats, known as arrhythmias. In May of this year, the Heart Rhythm Society released the first international guidelines for diagnosing